Cargando…
Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing
INTRODUCTION: Lung tumor organoids (LTOs) have attracted attention as in vitro preclinical models; however, their clinical and experimental applications have not been fully established. METHODS: We attempted to establish LTOs from resected specimens of patients with lung cancer who underwent lung re...
Autores principales: | Koga, Takamasa, Soh, Junichi, Hamada, Akira, Miyano, Yuki, Fujino, Toshio, Obata, Keiko, Ohara, Shuta, Nishino, Masaya, Chiba, Masato, Shimoji, Masaki, Takemoto, Toshiki, Suda, Kenichi, Sakai, Kazuko, Sato, Hidenori, Mitsudomi, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480534/ https://www.ncbi.nlm.nih.gov/pubmed/37681218 http://dx.doi.org/10.1016/j.jtocrr.2023.100554 |
Ejemplares similares
-
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
por: Ohara, Shuta, et al.
Publicado: (2020) -
Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation
por: Fujino, Toshio, et al.
Publicado: (2022) -
Primary pulmonary mucosa-associated lymphoid tissue lymphoma with amyloid light chain-type amyloidosis
por: Ohara, Shuta, et al.
Publicado: (2019) -
Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC
por: Hamada, Akira, et al.
Publicado: (2022) -
Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study
por: Koga, Takamasa, et al.
Publicado: (2021)